Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2110-2121
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110
Figure 4
Figure 4 Forest plot for Cox proportional hazards model applied to the followed patients. Probiotics refers to esomeprazole 20 mg b.i.d. and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules 500 mg t.i.d. treatment; placebo refers to esomeprazole 20 mg b.i.d. and placebo treatment. aP < 0.05; bP < 0.01; cP < 0.001. RDQ: Reflux disease questionnaire; AIC: Akaike information criterion.